Filtriraj po Last updated date SelectPoznejePredFrom - To Date Končni datum This week This month Last week Last month Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationMedicine shortagesResearch and developmentBiosimilarsSMEAntimicrobial resistanceCorporateGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate usePRIMECareersMedication errorParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety information Patient safety Leave this field blank Filter Rezultati (3839) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank European Medicines Agency improves package leaflets 22 Julij 2011NewsMedicinesProduct information Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 18-21 July 2011 22 Julij 2011Press releaseHuman European Medicines Agency agrees to recall of Vimpat 15-mg/ml syrup 22 Julij 2011Press releaseHumanMedicines European Medicines Agency updates on ongoing benefit-risk review of Multaq 21 Julij 2011Press releaseHumanMedicines European Medicines Agency confirms positive benefit-risk balance for Champix 21 Julij 2011Press releaseHumanMedicines European Medicines Agency recommends new contra-indications and warnings for pioglitazone to reduce small increased risk of bladder cancer 21 Julij 2011Press releaseMedicines European Medicines Agency recommends restricting use of Pandemrix 21 Julij 2011Press releaseMedicines Sun Pharmaceutical Industries Europe B.V. withdraws its marketing authorisation application for Doxorubicin Sun (doxorubicin hydrochloride) 21 Julij 2011Press releaseHuman Pfizer Limited withdraws its application for an extension of the indication for Macugen (pegaptanib sodium) 19 Julij 2011Press release Public consultation opens on the revised guideline on good distribution practice of medicinal products for human use 19 Julij 2011NewsCompliance and inspectionsRegulatory and procedural guidance 1 … 271 272 273 274 275 Page 275 of 384 276 277 278 279 … 384
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 18-21 July 2011 22 Julij 2011Press releaseHuman
European Medicines Agency agrees to recall of Vimpat 15-mg/ml syrup 22 Julij 2011Press releaseHumanMedicines
European Medicines Agency updates on ongoing benefit-risk review of Multaq 21 Julij 2011Press releaseHumanMedicines
European Medicines Agency confirms positive benefit-risk balance for Champix 21 Julij 2011Press releaseHumanMedicines
European Medicines Agency recommends new contra-indications and warnings for pioglitazone to reduce small increased risk of bladder cancer 21 Julij 2011Press releaseMedicines
European Medicines Agency recommends restricting use of Pandemrix 21 Julij 2011Press releaseMedicines
Sun Pharmaceutical Industries Europe B.V. withdraws its marketing authorisation application for Doxorubicin Sun (doxorubicin hydrochloride) 21 Julij 2011Press releaseHuman
Pfizer Limited withdraws its application for an extension of the indication for Macugen (pegaptanib sodium) 19 Julij 2011Press release
Public consultation opens on the revised guideline on good distribution practice of medicinal products for human use 19 Julij 2011NewsCompliance and inspectionsRegulatory and procedural guidance